Tata Mutual Fund
Up to one year: absolute. Longer: annualised. Category = median of Index Funds regular-plan Growth funds.
| Period | This fund | Category median | Rank in category |
|---|---|---|---|
| 1 month | -2.38% | -5.41% | — |
| 3 months | +2.11% | -4.23% | — |
| 6 months | +20.83% | +3.42% | — |
| 1 year | +15.88% | +1.44% | #7 of 311 Top 3% |
| 3 years | — | +7.18% | — |
| 5 years | — | +5.93% | — |
| 10 years | — | +10.44% | — |
| Since launch of NAV data | +16.96% | — | — |
| Window | High | Low |
|---|---|---|
| 1 month | 15.3736 | 14.7286 |
| 3 months | 15.3736 | 14.4238 |
| 6 months | 15.3736 | 12.1079 |
| 1 year | 15.3736 | 11.8744 |
A period is a dash when the fund has not existed that long or its NAV history has a hole at the start date — never a partial figure.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | YTD | |
|---|---|---|---|---|---|---|---|
| This fund | — | — | — | — | — | -1.53% | +15.51% |
| Category median | +15.16% | +24.84% | +2.78% | +20.60% | +9.56% | +7.62% | -2.94% |
Twenty checks of five points each: performance, portfolio, operations, and risk against reward. Only checks we have data for are counted.
Risk-free rate 6.06% (3-year annualised return of the NSE 1-day (overnight) rate index). This category has no reference index in our data, so benchmark-relative ratios are not shown.
| Ratio | This fund | Category median | Against category |
|---|---|---|---|
| Sharpe ratio | — | 0.37 | — |
| Sortino ratio | — | 0.54 | — |
| Standard deviation | — | 13.27% | — |
| Maximum drawdown | — | -15.66% | — |
| Beta | — | 1.00 | — |
| R-squared | — | 100.0% | — |
| Jensen's alpha | — | -1.00% | — |
| Treynor ratio | — | 1.53 | — |
| Information ratio | — | -7.68 | — |
| Upside capture | — | 99.3% | — |
| Downside capture | — | 100.4% | — |
Computed from this fund's actual NAVs. A SIP buys at the first NAV of each month and is valued at the latest NAV. Past returns do not guarantee future ones.
Weights are % of the scheme's assets from the latest month-end disclosure available to Tradinity. Shown from the Direct plan of this fund, which holds the same portfolio. The feed carries weights only: no quantities or rupee values.
Valuation ratios are weighted over the holdings we can match to a company (harmonic mean for P/E) and are withheld when they cover under half the portfolio.
| Holding | Sector | Weight | 3M change | P/E |
|---|---|---|---|---|
| PORTFOLIO TOTAL | — | 100.21% | — | — |
| EQUITY & EQUITY RELATED TOTAL | — | 100.13% | — | — |
| LAURUS LABS LTD | Healthcare | 11.22% | — | 122.0 |
| LUPIN LTD | Healthcare | 8.01% | — | 13.2 |
| AUROBINDO PHARMA LTD | Healthcare | 7.16% | — | 37.5 |
| FORTIS HEALTHCARE LTD | Healthcare | 7.12% | — | 255.5 |
| GLENMARK PHARMACEUTICALS LTD | Healthcare | 5.62% | — | 316.1 |
| ALKEM LABORATORIES LTD | Healthcare | 4.70% | — | 29.1 |
| BIOCON LTD | Healthcare | 4.43% | — | 596.5 |
| IPCA LABORATORIES LTD | Healthcare | 4.13% | — | 39.8 |
| MANKIND PHARMA LTD | Healthcare | 4.13% | — | 46.9 |
| GLAND PHARMA LTD | Healthcare | 3.46% | — | 34.4 |
| SAI LIFE SCIENCES LTD | Healthcare | 3.03% | — | 89.9 |
| NEULAND LABORATORIES LTD | Healthcare | 2.99% | — | 56.5 |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD | Healthcare | 2.95% | — | 105.1 |
| ASTER DM QUALITY CARE LTD | Healthcare | 2.88% | — | 205.8 |
| ACUTAAS CHEMICALS LTD | Healthcare | 2.47% | — | 64.3 |
| WOCKHARDT LTD | Healthcare | 2.34% | — | 94.2 |
| AJANTA PHARMA LTD | Healthcare | 2.29% | — | 43.2 |
| DR. LAL PATH LABS LTD | Healthcare | 2.27% | — | 38.4 |
| ABBOTT INDIA LTD | Healthcare | 2.03% | — | 34.5 |
| PIRAMAL PHARMA LTD | Healthcare | 2.01% | — | 37.0 |
| NARAYANA HRUDAYALAYA LTD | Healthcare | 1.98% | — | 61.9 |
| GLOBAL HEALTH LTD | Healthcare | 1.91% | — | 74.4 |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD | Healthcare | 1.90% | — | 43.8 |
| GRANULES INDIA LTD | Healthcare | 1.81% | — | 49.5 |
| ONESOURCE SPECIALTY PHARMA LTD | Healthcare | 1.80% | — | 358.6 |
| SYNGENE INTERNATIONAL LTD | Healthcare | 1.15% | — | 62.8 |
| NATCO PHARMA LTD | Healthcare | 1.14% | — | 16.5 |
| COHANCE LIFESCIENCES LTD | Healthcare | 1.12% | — | 96.3 |
| PFIZER LTD | Healthcare | 1.07% | — | 23.9 |
| POLY MEDICURE LTD | Healthcare | 1.01% | — | 48.8 |
| I) REPO | — | 0.08% | — | — |
This is a paid feature
Comparing more months of this fund's own portfolio history is available on paid plans.
Sign inExpense ratio by month: Oct 25 1.11% · Nov 25 1.11% · Dec 25 1.11% · Jan 26 1.12% · Feb 26 1.12% · Mar 26 1.12% · Apr 26 1.06% · May 26 0.99% · Jun 26 1.06% · Jul 26 1.07% · Aug 26 1.15% · Sep 26 1.12%
0.25% of the applicable NAV, if redeemed on or before 15 days from the date of allotment.
The investment objective of the scheme is to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The scheme does not assure or guarantee any returns
Fund house: website · factsheets · monthly portfolio · annual report
Not available: Morningstar rating (proprietary). "NAV history from" is the first NAV we hold.
Returns are computed by Tradinity from each scheme's own published NAV, so they are net of the fund's expenses. Periods over one year are annualised (CAGR). Past performance does not indicate future returns. Only Growth-option schemes are ranked: an IDCW scheme pays cash out of its NAV, so its NAV understates what an investor earned.
